Brainomix
To add a bio or update company history, please click update information.
News from Brainomix
Brainomix
24 Feb 2026
Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis
Brainomix develops medical imaging software that helps clinicians assess stroke and lung fibrosis using automated image analysis. Its platforms support diagnosis and treatment decisions by analysing scans and providing clinical insights at the point of care.
Brainomix
20 Mar 2025
Brainomix completes £14m Series C led by Parkwalk Advisors to advance AI imaging technology in healthcare
Brainomix develops AI-powered medical imaging software for stroke and lung disease, helping clinicians diagnose conditions faster and make better treatment decisions using automated biomarkers.
Brainomix
- Health
- Oxford, United Kingdom
- £18.8m
- brainomix.com
- Update Information
More venture news
- 29 Jul 2026
MiraeMirae lands £4m in funding from Oxford Science Enterprises for conversational AI platform that tracks autoimmune disease between clinic visits
EquityHealth - 28 Jul 2026
DITTODITTO lands a £4.5m seed round led by FoodLabs to develop evidence-based menstrual health supplements
SeedHealth - 24 Jul 2026
TidalSenseTidalSense secures £14m in funding from VCs to roll out AI-driven breath test for lung disease
EquityHealth
